Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 7, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
ABL lands £2B deal with GSK based on BBB passing drug platform
BioWorld
ABL Bio Inc. announced April 7 that it sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s...